BioCentury
ARTICLE | Emerging Company Profile

Led by ElevateBio’s Finer, LifeEDIT is pursuing novel enzymes for gene editing

Emerging Company Profile: AgBiome spinout LifeEDIT gains funding, gene and cell therapy expertise from ElevateBio

November 18, 2020 2:12 AM UTC

LifeEDIT debuted with undisclosed funding from ElevateBio and former parent company AgBiome this week to develop novel RNA-guided nucleases and base editors that could offer broader genome access than existing genome editing enzymes. 

With access to ElevateBio’s gene and cell therapy processing and manufacturing resources, the company plans to both develop an internal pipeline and therapies with partners including fellow ElevateBio portfolio companies. ...

BCIQ Company Profiles

ElevateBio LLC